Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intan Baru Prana Tbk. (IBFN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Intan Baru Prana Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Intan Baru Prana Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.7× Intan Baru Prana Tbk.'s market cap, and Intan Baru Prana Tbk. is more actively traded (799.4K versus 635.5K). Which is the better fit depends on your goals.

IBFNLABS
Market Cap
103.18B691.25B
Volume
799.4K635.5K
Lot
7.99K6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IBFN
View details
LABS
View details

About Intan Baru Prana Tbk.

PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.

Read more on IBFN

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS